Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

2',5'-Oligoadenylate Synthetase 1, 40/46kDa (OAS1) (N-Term) Peptide

OAS1 Reactivity: Human Host: Synthetic BP, WB, IHC
Catalog No. ABIN981069

Quick Overview for 2',5'-Oligoadenylate Synthetase 1, 40/46kDa (OAS1) (N-Term) Peptide (ABIN981069)

Target

OAS1 (2',5'-Oligoadenylate Synthetase 1, 40/46kDa (OAS1))

Origin

Human

Source

  • 9
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Protein Region

    N-Term

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-OAS1 antibody (Catalog #: ARP40401_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    OAS1 (2',5'-Oligoadenylate Synthetase 1, 40/46kDa (OAS1))

    Background

    This protein is a member of the 2-5A synthetase family, essential proteins involved in the innate immune response to viral infection. The encoded protein is induced by interferons and uses adenosine triphosphate in 2'-specific nucleotidyl transfer reactio

    Alias Symbols: IFI-4, OIAS, OIASI

    Protein Size: 364

    Molecular Weight

    42 kDa

    Gene ID

    4938

    NCBI Accession

    NM_024833, NP_002525
You are here:
Chat with us!